Skip to main content
Top
Published in: World Journal of Urology 4/2014

01-08-2014 | Original Article

Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation

Authors: Giovanni Palleschi, Antonio Luigi Pastore, Cristina Maggioni, Andrea Fuschi, Luca Pacini, Vincenzo Petrozza, Antonio Carbone

Published in: World Journal of Urology | Issue 4/2014

Login to get access

Abstract

Purpose

Bladder dysfunction, secondary to diabetes, is mainly characterized by poor bladder emptying and overflow incontinence. However, there is evidence in literature that storage symptoms, as those suggestive for overactive bladder (OAB), may also affect people with diabetes. The aim of this study was to evaluate the prevalence of overactive bladder, the complaint of urinary urgency with/without urge incontinence, usually with frequency and nocturia, in people with diabetes compared to healthy subjects (control group).

Methods

Symptoms were assessed through the overactive bladder questionnaire (OAB-q), an investigative tool, specifically developed for OAB diagnosis.

Results

OAB-q scores resulted higher in diabetic people than those of the control group. Age and disease duration resulted in measurements that showed a statistical correlation with the OAB-q scores.

Conclusions

OAB symptoms are more prevalent in diabetic people than in non-diabetic people. This prompts further research to determine whether the onset of OAB symptoms can be considered as an indicator of diabetic neuropathy.
Literature
1.
go back to reference Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmstein U, Van Kerrebroek P, Victor A, Wein A (2003) The standardization of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61(1):37–49PubMedCrossRef Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmstein U, Van Kerrebroek P, Victor A, Wein A (2003) The standardization of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61(1):37–49PubMedCrossRef
2.
go back to reference Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(1):S5–S20 Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(1):S5–S20
3.
go back to reference Coyne K, Revicki D, Hunt T, Correy R, Stuart W, Bentkover J, Kurth H, Abrams P (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11(6):563–574PubMedCrossRef Coyne K, Revicki D, Hunt T, Correy R, Stuart W, Bentkover J, Kurth H, Abrams P (2002) Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 11(6):563–574PubMedCrossRef
4.
go back to reference Coyne KS, Tubaro A, Brubacker L, Bavendam T (2006) Development and validation of patient reported outcome measures for overactive bladder: a review of concepts. Urology 2006 Coyne KS, Tubaro A, Brubacker L, Bavendam T (2006) Development and validation of patient reported outcome measures for overactive bladder: a review of concepts. Urology 2006
5.
go back to reference Wiedemann A, Fugsen I (2010) The patient with diabetes in urologic practice: a special risk for lower urinary tract symptoms? Results of the Witten diabetes survey of 4071 type 2 diabetics. Urol A 49(2):238–244CrossRef Wiedemann A, Fugsen I (2010) The patient with diabetes in urologic practice: a special risk for lower urinary tract symptoms? Results of the Witten diabetes survey of 4071 type 2 diabetics. Urol A 49(2):238–244CrossRef
6.
go back to reference Pannek J (2010) Diagnosis and therapy of functional disorders of the bladder in persons with diabetes mellitus. What do we actually know? Urol A 49(3):381–386CrossRef Pannek J (2010) Diagnosis and therapy of functional disorders of the bladder in persons with diabetes mellitus. What do we actually know? Urol A 49(3):381–386CrossRef
7.
go back to reference Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S (2009) Diabetic bladder dysfunction: current translational knowledge. J Urol 182(6 Suppl):S18–S26PubMedCrossRef Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S (2009) Diabetic bladder dysfunction: current translational knowledge. J Urol 182(6 Suppl):S18–S26PubMedCrossRef
8.
go back to reference Lee WC, Wu HP, Tai TY, Yu HJ, Chiang PH (2009) Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes. J Urol 181(1):198–203PubMedCrossRef Lee WC, Wu HP, Tai TY, Yu HJ, Chiang PH (2009) Investigation of urodynamic characteristics and bladder sensory function in the early stages of diabetic bladder dysfunction in women with type 2 diabetes. J Urol 181(1):198–203PubMedCrossRef
9.
go back to reference Ding J, Qi L, Zu X, Shen P (2010) Urodynamic studies on benign prostatic hyperplasia combined with diabetes mellitus. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35(7):705–710PubMed Ding J, Qi L, Zu X, Shen P (2010) Urodynamic studies on benign prostatic hyperplasia combined with diabetes mellitus. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35(7):705–710PubMed
10.
go back to reference Ho CH, Tai HC, Yu HJ (2010) Urodynamic findings in female diabetic patients with and without overactive bladder symptoms. Neurourol Urodyn 29(3):424–427PubMed Ho CH, Tai HC, Yu HJ (2010) Urodynamic findings in female diabetic patients with and without overactive bladder symptoms. Neurourol Urodyn 29(3):424–427PubMed
11.
go back to reference Tong YC, Cheng JT (2007) Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats. J Urol 178(5):2203–2207PubMedCrossRef Tong YC, Cheng JT (2007) Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats. J Urol 178(5):2203–2207PubMedCrossRef
12.
go back to reference Atalik KE, Okudan N, Gokbel H, Kalkan S, Cuce G (2010) Diabetes mellitus- and cooling-induced bladder contraction: an in vitro study. J Smooth Muscle Res 46(4):175–183PubMedCrossRef Atalik KE, Okudan N, Gokbel H, Kalkan S, Cuce G (2010) Diabetes mellitus- and cooling-induced bladder contraction: an in vitro study. J Smooth Muscle Res 46(4):175–183PubMedCrossRef
13.
go back to reference Fayyad AM, Hill SR, Jones G (2009) Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int Urogynecol J 20:1339–1344CrossRef Fayyad AM, Hill SR, Jones G (2009) Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int Urogynecol J 20:1339–1344CrossRef
14.
go back to reference Yamaguchi C, Sakakibara R, Uchiyama T, Yamamoto T, Ito T, Liu Z, Awa Y, Yamamoto K, Nomura F, Yamanishi T, Hattori T (2007) Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodyn 26(6):807–813PubMedCrossRef Yamaguchi C, Sakakibara R, Uchiyama T, Yamamoto T, Ito T, Liu Z, Awa Y, Yamamoto K, Nomura F, Yamanishi T, Hattori T (2007) Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodyn 26(6):807–813PubMedCrossRef
15.
go back to reference Iacovelli E, Gilio F, Meco G, Fattapposta F, Vanacore N, Brusa L, Giacomelli E, Gabriele M, Rubino A, Locuratolo N, Iani C, Pichiorri F, Colosimo C, Carbone A, Palleschi G, Inghilleri M (2010) Bladder symptoms assessed with overactive bladder questionnaire in Parkinson’s disease. Mov Dis 25(9):1203–1209 Iacovelli E, Gilio F, Meco G, Fattapposta F, Vanacore N, Brusa L, Giacomelli E, Gabriele M, Rubino A, Locuratolo N, Iani C, Pichiorri F, Colosimo C, Carbone A, Palleschi G, Inghilleri M (2010) Bladder symptoms assessed with overactive bladder questionnaire in Parkinson’s disease. Mov Dis 25(9):1203–1209
16.
go back to reference Tubaro A (2004) Defining overactive bladder: epidemiology and burden of disease. Urology 64(6 Suppl 1):2–6PubMedCrossRef Tubaro A (2004) Defining overactive bladder: epidemiology and burden of disease. Urology 64(6 Suppl 1):2–6PubMedCrossRef
17.
go back to reference Fayyad AM, Hill SR, Jones G (2010) Urine production and bladder diary measurements in women with type 2 diabetes mellitus and their relation to lower urinary tract symptoms and voiding dysfunction. Neurourol Urodyn 29(3):354–358PubMed Fayyad AM, Hill SR, Jones G (2010) Urine production and bladder diary measurements in women with type 2 diabetes mellitus and their relation to lower urinary tract symptoms and voiding dysfunction. Neurourol Urodyn 29(3):354–358PubMed
18.
go back to reference Lin TL, Chen GD, Chen YC, Huang CN, Ng SC (2012) Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes. Source Dep Living Sci Nat Open Univ Taiwan 51(3):381–386 Lin TL, Chen GD, Chen YC, Huang CN, Ng SC (2012) Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes. Source Dep Living Sci Nat Open Univ Taiwan 51(3):381–386
19.
go back to reference Devore EE, Townsend MK, Resnick NM, Grodstein F (2012) The epidemiology of urinary incontinence in women with type 2 diabetes. J Urol 188(5):1816–1821PubMedCentralPubMedCrossRef Devore EE, Townsend MK, Resnick NM, Grodstein F (2012) The epidemiology of urinary incontinence in women with type 2 diabetes. J Urol 188(5):1816–1821PubMedCentralPubMedCrossRef
20.
go back to reference Wang Z, Cheng Z, Cristofaro V, Li J, Xiao X, Gomez P, Ge R, Gong E, Strle K, Sullivan MP, Adam RM, White MF (2012) Olumi AF Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes. Diabetes 61(8):2134–2145PubMedCentralPubMedCrossRef Wang Z, Cheng Z, Cristofaro V, Li J, Xiao X, Gomez P, Ge R, Gong E, Strle K, Sullivan MP, Adam RM, White MF (2012) Olumi AF Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes. Diabetes 61(8):2134–2145PubMedCentralPubMedCrossRef
21.
go back to reference Liu RT, Chung MS, Chuang YC, Lee JJ, Lee WC, Chang HW, Yang KD, Chancellor MB (2012) The presence of overactive bladder wet increased the risk and severity of erectile dysfunction in men with type 2 diabetes. J Sex Med 9(7):1913–1922PubMedCrossRef Liu RT, Chung MS, Chuang YC, Lee JJ, Lee WC, Chang HW, Yang KD, Chancellor MB (2012) The presence of overactive bladder wet increased the risk and severity of erectile dysfunction in men with type 2 diabetes. J Sex Med 9(7):1913–1922PubMedCrossRef
Metadata
Title
Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation
Authors
Giovanni Palleschi
Antonio Luigi Pastore
Cristina Maggioni
Andrea Fuschi
Luca Pacini
Vincenzo Petrozza
Antonio Carbone
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 4/2014
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1175-3

Other articles of this Issue 4/2014

World Journal of Urology 4/2014 Go to the issue